A novel TLR7 agonist as adjuvant to stimulate high quality HBsAg-specific immune responses in an HBV mouse model

BACKGROUND: The global burden of hepatitis B virus (HBV) infection in terms of morbidity and mortality is immense. Novel treatments that can induce a protective immune response are urgently needed to effectively control the HBV epidemic and eventually eradicate chronic HBV infection. METHODS: We des...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Yunlong, Tang, Li, Zhu, Zhengyu, Meng, He, Chen, Tingting, Zhao, Sheng, Jin, Zhenchao, Wang, Zhulin, Jin, Guangyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055022/
https://www.ncbi.nlm.nih.gov/pubmed/32131853
http://dx.doi.org/10.1186/s12967-020-02275-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055022/
https://www.ncbi.nlm.nih.gov/pubmed/32131853
http://dx.doi.org/10.1186/s12967-020-02275-2

Ejemplares similares